世界の筋骨格系医療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Musculoskeletal Medicine Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3976 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、155ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、筋骨格系医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、パッチ、カプセル、坐剤、注射剤、懸濁剤、塞栓剤、顆粒、その他）、用途別市場規模（整形外科鎮痛薬、解熱・鎮痛薬、非ステロイド系抗炎症薬、リウマチ性疾患薬、痛風薬耐性、ブルーイング傷害薬、グラビス筋無力症薬、遅効性抗リウマチ薬、関節・筋肉痛局所投与、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋骨格系医療の市場動向 ・企業の競争状況、市場シェア ・筋骨格系医療の種類別市場規模（錠剤、パッチ、カプセル、坐剤、注射剤、懸濁剤、塞栓剤、顆粒、その他） ・筋骨格系医療の用途別市場規模（整形外科鎮痛薬、解熱・鎮痛薬、非ステロイド系抗炎症薬、リウマチ性疾患薬、痛風薬耐性、ブルーイング傷害薬、グラビス筋無力症薬、遅効性抗リウマチ薬、関節・筋肉痛局所投与、その他） ・筋骨格系医療の北米市場規模2016-2027（アメリカ、カナダ） ・筋骨格系医療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋骨格系医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋骨格系医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋骨格系医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Mylan N.V.、Teva Pharmaceutical Industries Ltd、UCB S.A.、Novartis Pharmaceuticals、Roche Inc、Hospira Inc、Valeant Pharmaceuticals International, Inc、Dr. Reddy's Laboratories Ltd.、Sun Pharmaceutical Industries Ltd. Co. , Ltd、Sawai PharmaceuticalCo., Ltd、Endo International、Hikma Pharmaceuticals、Fresenius Kabi, LLC、Boehringer Ingelheim、Merck、GSK、Alter、Bayer、Rafa Laboratories、Grunenthal、Pfizer、Sanofi、Italfarmaco、Martec USA LLC、Acorda Therapeutics、Apotex Inc、CorePharma、Helsinn、Therabel、Sinopharm、Chinoin） ・結論

Market Analysis and Insights: Global Musculoskeletal Medicine Market
The global Musculoskeletal Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Musculoskeletal Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Musculoskeletal Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Musculoskeletal Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Musculoskeletal Medicine market.

Global Musculoskeletal Medicine Scope and Market Size
Musculoskeletal Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Musculoskeletal Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Dosage Form
Tablets
Patch
Capsule
Suppositories
Injection
Suspension Agent
Emplastrum
Granules
Other
by Route
Oral
Intravenous
Topical

Segment by Application
Orthopedic Analgesics
Antipyretic And Analgesic
Nonsteroidal Anti-Inflammatory Drugs
Drugs For Rheumatic Diseases
Gout Drug Resistance
Medication For Bruising Injuries
Myasthenia Gravis Medication
Slow Acting Antirheumatic Agent
Topical Administration For Joint And Muscle Pain

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Mylan N.V.
Teva Pharmaceutical Industries Ltd
UCB S.A.
Novartis Pharmaceuticals
Roche Inc
Hospira Inc
Valeant Pharmaceuticals International, Inc
Dr. Reddy’s Laboratories Ltd.
Sun Pharmaceutical Industries Ltd. Co. , Ltd
Sawai PharmaceuticalCo., Ltd
Endo International
Hikma Pharmaceuticals
Fresenius Kabi, LLC
Boehringer Ingelheim
Merck
GSK
Alter
Bayer
Rafa Laboratories
Grunenthal
Pfizer
Sanofi
Italfarmaco
Martec USA LLC
Acorda Therapeutics
Apotex Inc
CorePharma
Helsinn
Therabel

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Patch
1.2.4 Capsule
1.2.5 Suppositories
1.2.6 Injection
1.2.7 Suspension Agent
1.2.8 Emplastrum
1.2.9 Granules
1.2.10 Other
1.3 Market by Application
1.3.1 Global Musculoskeletal Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopedic Analgesics
1.3.3 Antipyretic And Analgesic
1.3.4 Nonsteroidal Anti-Inflammatory Drugs
1.3.5 Drugs For Rheumatic Diseases
1.3.6 Gout Drug Resistance
1.3.7 Medication For Bruising Injuries
1.3.8 Myasthenia Gravis Medication
1.3.9 Slow Acting Antirheumatic Agent
1.3.10 Topical Administration For Joint And Muscle Pain
1.3.11 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Musculoskeletal Medicine Market Perspective (2016-2027)
2.2 Musculoskeletal Medicine Growth Trends by Regions
2.2.1 Musculoskeletal Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Musculoskeletal Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Musculoskeletal Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Musculoskeletal Medicine Industry Dynamic
2.3.1 Musculoskeletal Medicine Market Trends
2.3.2 Musculoskeletal Medicine Market Drivers
2.3.3 Musculoskeletal Medicine Market Challenges
2.3.4 Musculoskeletal Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal Medicine Players by Revenue
3.1.1 Global Top Musculoskeletal Medicine Players by Revenue (2016-2021)
3.1.2 Global Musculoskeletal Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Musculoskeletal Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal Medicine Revenue
3.4 Global Musculoskeletal Medicine Market Concentration Ratio
3.4.1 Global Musculoskeletal Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Medicine Revenue in 2020
3.5 Musculoskeletal Medicine Key Players Head office and Area Served
3.6 Key Players Musculoskeletal Medicine Product Solution and Service
3.7 Date of Enter into Musculoskeletal Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Musculoskeletal Medicine Breakdown Data by Type
4.1 Global Musculoskeletal Medicine Historic Market Size by Type (2016-2021)
4.2 Global Musculoskeletal Medicine Forecasted Market Size by Type (2022-2027)

5 Musculoskeletal Medicine Breakdown Data by Application
5.1 Global Musculoskeletal Medicine Historic Market Size by Application (2016-2021)
5.2 Global Musculoskeletal Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Musculoskeletal Medicine Market Size (2016-2027)
6.2 North America Musculoskeletal Medicine Market Size by Type
6.2.1 North America Musculoskeletal Medicine Market Size by Type (2016-2021)
6.2.2 North America Musculoskeletal Medicine Market Size by Type (2022-2027)
6.2.3 North America Musculoskeletal Medicine Market Size by Type (2016-2027)
6.3 North America Musculoskeletal Medicine Market Size by Application
6.3.1 North America Musculoskeletal Medicine Market Size by Application (2016-2021)
6.3.2 North America Musculoskeletal Medicine Market Size by Application (2022-2027)
6.3.3 North America Musculoskeletal Medicine Market Size by Application (2016-2027)
6.4 North America Musculoskeletal Medicine Market Size by Country
6.4.1 North America Musculoskeletal Medicine Market Size by Country (2016-2021)
6.4.2 North America Musculoskeletal Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Musculoskeletal Medicine Market Size (2016-2027)
7.2 Europe Musculoskeletal Medicine Market Size by Type
7.2.1 Europe Musculoskeletal Medicine Market Size by Type (2016-2021)
7.2.2 Europe Musculoskeletal Medicine Market Size by Type (2022-2027)
7.2.3 Europe Musculoskeletal Medicine Market Size by Type (2016-2027)
7.3 Europe Musculoskeletal Medicine Market Size by Application
7.3.1 Europe Musculoskeletal Medicine Market Size by Application (2016-2021)
7.3.2 Europe Musculoskeletal Medicine Market Size by Application (2022-2027)
7.3.3 Europe Musculoskeletal Medicine Market Size by Application (2016-2027)
7.4 Europe Musculoskeletal Medicine Market Size by Country
7.4.1 Europe Musculoskeletal Medicine Market Size by Country (2016-2021)
7.4.2 Europe Musculoskeletal Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Medicine Market Size (2016-2027)
8.2 Asia-Pacific Musculoskeletal Medicine Market Size by Type
8.2.1 Asia-Pacific Musculoskeletal Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Musculoskeletal Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Musculoskeletal Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Musculoskeletal Medicine Market Size by Application
8.3.1 Asia-Pacific Musculoskeletal Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Musculoskeletal Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Musculoskeletal Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Musculoskeletal Medicine Market Size by Region
8.4.1 Asia-Pacific Musculoskeletal Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Musculoskeletal Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Musculoskeletal Medicine Market Size (2016-2027)
9.2 Latin America Musculoskeletal Medicine Market Size by Type
9.2.1 Latin America Musculoskeletal Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Musculoskeletal Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Musculoskeletal Medicine Market Size by Type (2016-2027)
9.3 Latin America Musculoskeletal Medicine Market Size by Application
9.3.1 Latin America Musculoskeletal Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Musculoskeletal Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Musculoskeletal Medicine Market Size by Application (2016-2027)
9.4 Latin America Musculoskeletal Medicine Market Size by Country
9.4.1 Latin America Musculoskeletal Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Musculoskeletal Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Medicine Market Size (2016-2027)
10.2 Middle East & Africa Musculoskeletal Medicine Market Size by Type
10.2.1 Middle East & Africa Musculoskeletal Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Musculoskeletal Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Musculoskeletal Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Musculoskeletal Medicine Market Size by Application
10.3.1 Middle East & Africa Musculoskeletal Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Musculoskeletal Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Musculoskeletal Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Musculoskeletal Medicine Market Size by Country
10.4.1 Middle East & Africa Musculoskeletal Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Musculoskeletal Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Mylan N.V.
11.1.1 Mylan N.V. Company Details
11.1.2 Mylan N.V. Business Overview
11.1.3 Mylan N.V. Musculoskeletal Medicine Introduction
11.1.4 Mylan N.V. Revenue in Musculoskeletal Medicine Business (2016-2021)
11.1.5 Mylan N.V. Recent Development
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Teva Pharmaceutical Industries Ltd Company Details
11.2.2 Teva Pharmaceutical Industries Ltd Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Introduction
11.2.4 Teva Pharmaceutical Industries Ltd Revenue in Musculoskeletal Medicine Business (2016-2021)
11.2.5 Teva Pharmaceutical Industries Ltd Recent Development
11.3 UCB S.A.
11.3.1 UCB S.A. Company Details
11.3.2 UCB S.A. Business Overview
11.3.3 UCB S.A. Musculoskeletal Medicine Introduction
11.3.4 UCB S.A. Revenue in Musculoskeletal Medicine Business (2016-2021)
11.3.5 UCB S.A. Recent Development
11.4 Novartis Pharmaceuticals
11.4.1 Novartis Pharmaceuticals Company Details
11.4.2 Novartis Pharmaceuticals Business Overview
11.4.3 Novartis Pharmaceuticals Musculoskeletal Medicine Introduction
11.4.4 Novartis Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2016-2021)
11.4.5 Novartis Pharmaceuticals Recent Development
11.5 Roche Inc
11.5.1 Roche Inc Company Details
11.5.2 Roche Inc Business Overview
11.5.3 Roche Inc Musculoskeletal Medicine Introduction
11.5.4 Roche Inc Revenue in Musculoskeletal Medicine Business (2016-2021)
11.5.5 Roche Inc Recent Development
11.6 Hospira Inc
11.6.1 Hospira Inc Company Details
11.6.2 Hospira Inc Business Overview
11.6.3 Hospira Inc Musculoskeletal Medicine Introduction
11.6.4 Hospira Inc Revenue in Musculoskeletal Medicine Business (2016-2021)
11.6.5 Hospira Inc Recent Development
11.7 Valeant Pharmaceuticals International, Inc
11.7.1 Valeant Pharmaceuticals International, Inc Company Details
11.7.2 Valeant Pharmaceuticals International, Inc Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Introduction
11.7.4 Valeant Pharmaceuticals International, Inc Revenue in Musculoskeletal Medicine Business (2016-2021)
11.7.5 Valeant Pharmaceuticals International, Inc Recent Development
11.8 Dr. Reddy’s Laboratories Ltd.
11.8.1 Dr. Reddy’s Laboratories Ltd. Company Details
11.8.2 Dr. Reddy’s Laboratories Ltd. Business Overview
11.8.3 Dr. Reddy’s Laboratories Ltd. Musculoskeletal Medicine Introduction
11.8.4 Dr. Reddy’s Laboratories Ltd. Revenue in Musculoskeletal Medicine Business (2016-2021)
11.8.5 Dr. Reddy’s Laboratories Ltd. Recent Development
11.9 Sun Pharmaceutical Industries Ltd. Co. , Ltd
11.9.1 Sun Pharmaceutical Industries Ltd. Co. , Ltd Company Details
11.9.2 Sun Pharmaceutical Industries Ltd. Co. , Ltd Business Overview
11.9.3 Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Introduction
11.9.4 Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue in Musculoskeletal Medicine Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries Ltd. Co. , Ltd Recent Development
11.10 Sawai PharmaceuticalCo., Ltd
11.10.1 Sawai PharmaceuticalCo., Ltd Company Details
11.10.2 Sawai PharmaceuticalCo., Ltd Business Overview
11.10.3 Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Introduction
11.10.4 Sawai PharmaceuticalCo., Ltd Revenue in Musculoskeletal Medicine Business (2016-2021)
11.10.5 Sawai PharmaceuticalCo., Ltd Recent Development
11.11 Endo International
11.11.1 Endo International Company Details
11.11.2 Endo International Business Overview
11.11.3 Endo International Musculoskeletal Medicine Introduction
11.11.4 Endo International Revenue in Musculoskeletal Medicine Business (2016-2021)
11.11.5 Endo International Recent Development
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Details
11.12.2 Hikma Pharmaceuticals Business Overview
11.12.3 Hikma Pharmaceuticals Musculoskeletal Medicine Introduction
11.12.4 Hikma Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2016-2021)
11.12.5 Hikma Pharmaceuticals Recent Development
11.13 Fresenius Kabi, LLC
11.13.1 Fresenius Kabi, LLC Company Details
11.13.2 Fresenius Kabi, LLC Business Overview
11.13.3 Fresenius Kabi, LLC Musculoskeletal Medicine Introduction
11.13.4 Fresenius Kabi, LLC Revenue in Musculoskeletal Medicine Business (2016-2021)
11.13.5 Fresenius Kabi, LLC Recent Development
11.14 Boehringer Ingelheim
11.14.1 Boehringer Ingelheim Company Details
11.14.2 Boehringer Ingelheim Business Overview
11.14.3 Boehringer Ingelheim Musculoskeletal Medicine Introduction
11.14.4 Boehringer Ingelheim Revenue in Musculoskeletal Medicine Business (2016-2021)
11.14.5 Boehringer Ingelheim Recent Development
11.15 Merck
11.15.1 Merck Company Details
11.15.2 Merck Business Overview
11.15.3 Merck Musculoskeletal Medicine Introduction
11.15.4 Merck Revenue in Musculoskeletal Medicine Business (2016-2021)
11.15.5 Merck Recent Development
11.16 GSK
11.16.1 GSK Company Details
11.16.2 GSK Business Overview
11.16.3 GSK Musculoskeletal Medicine Introduction
11.16.4 GSK Revenue in Musculoskeletal Medicine Business (2016-2021)
11.16.5 GSK Recent Development
11.17 Alter
11.17.1 Alter Company Details
11.17.2 Alter Business Overview
11.17.3 Alter Musculoskeletal Medicine Introduction
11.17.4 Alter Revenue in Musculoskeletal Medicine Business (2016-2021)
11.17.5 Alter Recent Development
11.18 Bayer
11.18.1 Bayer Company Details
11.18.2 Bayer Business Overview
11.18.3 Bayer Musculoskeletal Medicine Introduction
11.18.4 Bayer Revenue in Musculoskeletal Medicine Business (2016-2021)
11.18.5 Bayer Recent Development
11.18 Rafa Laboratories
11.25.1 Rafa Laboratories Company Details
11.25.2 Rafa Laboratories Business Overview
11.25.3 Rafa Laboratories Musculoskeletal Medicine Introduction
11.25.4 Rafa Laboratories Revenue in Musculoskeletal Medicine Business (2016-2021)
11.25.5 Rafa Laboratories Recent Development
11.20 Grunenthal
11.20.1 Grunenthal Company Details
11.20.2 Grunenthal Business Overview
11.20.3 Grunenthal Musculoskeletal Medicine Introduction
11.20.4 Grunenthal Revenue in Musculoskeletal Medicine Business (2016-2021)
11.20.5 Grunenthal Recent Development
11.21 Pfizer
11.21.1 Pfizer Company Details
11.21.2 Pfizer Business Overview
11.21.3 Pfizer Musculoskeletal Medicine Introduction
11.21.4 Pfizer Revenue in Musculoskeletal Medicine Business (2016-2021)
11.21.5 Pfizer Recent Development
11.22 Sanofi
11.22.1 Sanofi Company Details
11.22.2 Sanofi Business Overview
11.22.3 Sanofi Musculoskeletal Medicine Introduction
11.22.4 Sanofi Revenue in Musculoskeletal Medicine Business (2016-2021)
11.22.5 Sanofi Recent Development
11.23 Italfarmaco
11.23.1 Italfarmaco Company Details
11.23.2 Italfarmaco Business Overview
11.23.3 Italfarmaco Musculoskeletal Medicine Introduction
11.23.4 Italfarmaco Revenue in Musculoskeletal Medicine Business (2016-2021)
11.23.5 Italfarmaco Recent Development
11.24 Martec USA LLC
11.24.1 Martec USA LLC Company Details
11.24.2 Martec USA LLC Business Overview
11.24.3 Martec USA LLC Musculoskeletal Medicine Introduction
11.24.4 Martec USA LLC Revenue in Musculoskeletal Medicine Business (2016-2021)
11.24.5 Martec USA LLC Recent Development
11.25 Acorda Therapeutics
11.25.1 Acorda Therapeutics Company Details
11.25.2 Acorda Therapeutics Business Overview
11.25.3 Acorda Therapeutics Musculoskeletal Medicine Introduction
11.25.4 Acorda Therapeutics Revenue in Musculoskeletal Medicine Business (2016-2021)
11.25.5 Acorda Therapeutics Recent Development
11.26 Apotex Inc
11.26.1 Apotex Inc Company Details
11.26.2 Apotex Inc Business Overview
11.26.3 Apotex Inc Musculoskeletal Medicine Introduction
11.26.4 Apotex Inc Revenue in Musculoskeletal Medicine Business (2016-2021)
11.26.5 Apotex Inc Recent Development
11.27 CorePharma
11.27.1 CorePharma Company Details
11.27.2 CorePharma Business Overview
11.27.3 CorePharma Musculoskeletal Medicine Introduction
11.27.4 CorePharma Revenue in Musculoskeletal Medicine Business (2016-2021)
11.27.5 CorePharma Recent Development
11.28 Helsinn
11.28.1 Helsinn Company Details
11.28.2 Helsinn Business Overview
11.28.3 Helsinn Musculoskeletal Medicine Introduction
11.28.4 Helsinn Revenue in Musculoskeletal Medicine Business (2016-2021)
11.28.5 Helsinn Recent Development
11.29 Therabel
11.29.1 Therabel Company Details
11.29.2 Therabel Business Overview
11.29.3 Therabel Musculoskeletal Medicine Introduction
11.29.4 Therabel Revenue in Musculoskeletal Medicine Business (2016-2021)
11.29.5 Therabel Recent Development
11.30 Sinopharm
11.30.1 Sinopharm Company Details
11.30.2 Sinopharm Business Overview
11.30.3 Sinopharm Musculoskeletal Medicine Introduction
11.30.4 Sinopharm Revenue in Musculoskeletal Medicine Business (2016-2021)
11.30.5 Sinopharm Recent Development
11.31 Chinoin
11.31.1 Chinoin Company Details
11.31.2 Chinoin Business Overview
11.31.3 Chinoin Musculoskeletal Medicine Introduction
11.31.4 Chinoin Revenue in Musculoskeletal Medicine Business (2016-2021)
11.31.5 Chinoin Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Musculoskeletal Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Patch
Table 4. Key Players of Capsule
Table 5. Key Players of Suppositories
Table 6. Key Players of Injection
Table 7. Key Players of Suspension Agent
Table 8. Key Players of Emplastrum
Table 9. Key Players of Granules
Table 10. Key Players of Other
Table 11. Global Musculoskeletal Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Musculoskeletal Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Musculoskeletal Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Musculoskeletal Medicine Market Share by Regions (2016-2021)
Table 15. Global Musculoskeletal Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Musculoskeletal Medicine Market Share by Regions (2022-2027)
Table 17. Musculoskeletal Medicine Market Trends
Table 18. Musculoskeletal Medicine Market Drivers
Table 19. Musculoskeletal Medicine Market Challenges
Table 20. Musculoskeletal Medicine Market Restraints
Table 21. Global Musculoskeletal Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Musculoskeletal Medicine Market Share by Players (2016-2021)
Table 23. Global Top Musculoskeletal Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Medicine as of 2020)
Table 24. Ranking of Global Top Musculoskeletal Medicine Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Musculoskeletal Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Musculoskeletal Medicine Product Solution and Service
Table 28. Date of Enter into Musculoskeletal Medicine Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Musculoskeletal Medicine Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Musculoskeletal Medicine Revenue Market Share by Type (2016-2021)
Table 32. Global Musculoskeletal Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Musculoskeletal Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Musculoskeletal Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Musculoskeletal Medicine Revenue Market Share by Application (2016-2021)
Table 36. Global Musculoskeletal Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Musculoskeletal Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Musculoskeletal Medicine Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Musculoskeletal Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Musculoskeletal Medicine Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Musculoskeletal Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Musculoskeletal Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Musculoskeletal Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Musculoskeletal Medicine Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Musculoskeletal Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Musculoskeletal Medicine Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Musculoskeletal Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Musculoskeletal Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Musculoskeletal Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Musculoskeletal Medicine Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Musculoskeletal Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Musculoskeletal Medicine Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Musculoskeletal Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Musculoskeletal Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Musculoskeletal Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Musculoskeletal Medicine Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Musculoskeletal Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Musculoskeletal Medicine Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Musculoskeletal Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Musculoskeletal Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Musculoskeletal Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Musculoskeletal Medicine Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Musculoskeletal Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Musculoskeletal Medicine Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Musculoskeletal Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Musculoskeletal Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Musculoskeletal Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 68. Mylan N.V. Company Details
Table 69. Mylan N.V. Business Overview
Table 70. Mylan N.V. Musculoskeletal Medicine Product
Table 71. Mylan N.V. Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 72. Mylan N.V. Recent Development
Table 73. Teva Pharmaceutical Industries Ltd Company Details
Table 74. Teva Pharmaceutical Industries Ltd Business Overview
Table 75. Teva Pharmaceutical Industries Ltd Musculoskeletal Medicine Product
Table 76. Teva Pharmaceutical Industries Ltd Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 77. Teva Pharmaceutical Industries Ltd Recent Development
Table 78. UCB S.A. Company Details
Table 79. UCB S.A. Business Overview
Table 80. UCB S.A. Musculoskeletal Medicine Product
Table 81. UCB S.A. Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 82. UCB S.A. Recent Development
Table 83. Novartis Pharmaceuticals Company Details
Table 84. Novartis Pharmaceuticals Business Overview
Table 85. Novartis Pharmaceuticals Musculoskeletal Medicine Product
Table 86. Novartis Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 87. Novartis Pharmaceuticals Recent Development
Table 88. Roche Inc Company Details
Table 89. Roche Inc Business Overview
Table 90. Roche Inc Musculoskeletal Medicine Product
Table 91. Roche Inc Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 92. Roche Inc Recent Development
Table 93. Hospira Inc Company Details
Table 94. Hospira Inc Business Overview
Table 95. Hospira Inc Musculoskeletal Medicine Product
Table 96. Hospira Inc Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 97. Hospira Inc Recent Development
Table 98. Valeant Pharmaceuticals International, Inc Company Details
Table 99. Valeant Pharmaceuticals International, Inc Business Overview
Table 100. Valeant Pharmaceuticals International, Inc Musculoskeletal Medicine Product
Table 101. Valeant Pharmaceuticals International, Inc Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 102. Valeant Pharmaceuticals International, Inc Recent Development
Table 103. Dr. Reddy's Laboratories Ltd. Company Details
Table 104. Dr. Reddy's Laboratories Ltd. Business Overview
Table 105. Dr. Reddy's Laboratories Ltd. Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 106. Dr. Reddy's Laboratories Ltd. Recent Development
Table 107. Sun Pharmaceutical Industries Ltd. Co. , Ltd Company Details
Table 108. Sun Pharmaceutical Industries Ltd. Co. , Ltd Business Overview
Table 109. Sun Pharmaceutical Industries Ltd. Co. , Ltd Musculoskeletal Medicine Product
Table 110. Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 111. Sun Pharmaceutical Industries Ltd. Co. , Ltd Recent Development
Table 112. Sawai PharmaceuticalCo., Ltd Company Details
Table 113. Sawai PharmaceuticalCo., Ltd Business Overview
Table 114. Sawai PharmaceuticalCo., Ltd Musculoskeletal Medicine Product
Table 115. Sawai PharmaceuticalCo., Ltd Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 116. Sawai PharmaceuticalCo., Ltd Recent Development
Table 117. Endo International Company Details
Table 118. Endo International Business Overview
Table 119. Endo International Musculoskeletal Medicine Product
Table 120. Endo International Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 121. Endo International Recent Development
Table 122. Hikma Pharmaceuticals Company Details
Table 123. Hikma Pharmaceuticals Business Overview
Table 124. Hikma Pharmaceuticals Musculoskeletal Medicine Product
Table 125. Hikma Pharmaceuticals Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 126. Hikma Pharmaceuticals Recent Development
Table 127. Fresenius Kabi, LLC Company Details
Table 128. Fresenius Kabi, LLC Business Overview
Table 129. Fresenius Kabi, LLC Musculoskeletal Medicine Product
Table 130. Fresenius Kabi, LLC Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 131. Fresenius Kabi, LLC Recent Development
Table 132. Boehringer Ingelheim Company Details
Table 133. Boehringer Ingelheim Business Overview
Table 134. Boehringer Ingelheim Musculoskeletal Medicine Product
Table 135. Boehringer Ingelheim Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 136. Boehringer Ingelheim Recent Development
Table 137. Merck Company Details
Table 138. Merck Business Overview
Table 139. Merck Musculoskeletal Medicine Product
Table 140. Merck Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 141. Merck Recent Development
Table 142. GSK Company Details
Table 143. GSK Business Overview
Table 144. GSK Musculoskeletal Medicine Product
Table 145. GSK Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 146. GSK Recent Development
Table 147. Alter Company Details
Table 148. Alter Business Overview
Table 149. Alter Musculoskeletal Medicine Product
Table 150. Alter Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 151. Alter Recent Development
Table 152. Bayer Company Details
Table 153. Bayer Business Overview
Table 154. Bayer Musculoskeletal Medicine Product
Table 155. Bayer Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 156. Bayer Recent Development
Table 157. Rafa Laboratories Company Details
Table 158. Rafa Laboratories Business Overview
Table 159. Rafa Laboratories Musculoskeletal Medicine Product
Table 160. Rafa Laboratories Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 161. Rafa Laboratories Recent Development
Table 162. Grunenthal Company Details
Table 163. Grunenthal Business Overview
Table 164. Grunenthal Musculoskeletal Medicine Product
Table 165. Grunenthal Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 166. Grunenthal Recent Development
Table 167. Pfizer Company Details
Table 168. Pfizer Business Overview
Table 169. Pfizer Musculoskeletal Medicine Product
Table 170. Pfizer Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 171. Pfizer Recent Development
Table 172. Sanofi Company Details
Table 173. Sanofi Business Overview
Table 174. Sanofi Musculoskeletal Medicine Product
Table 175. Sanofi Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 176. Sanofi Recent Development
Table 177. Italfarmaco Company Details
Table 178. Italfarmaco Business Overview
Table 179. Italfarmaco Musculoskeletal Medicine Product
Table 180. Italfarmaco Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 181. Italfarmaco Recent Development
Table 182. Martec USA LLC Company Details
Table 183. Martec USA LLC Business Overview
Table 184. Martec USA LLC Musculoskeletal MedicineProduct
Table 185. Martec USA LLC Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 186. Martec USA LLC Recent Development
Table 187. Acorda Therapeutics Company Details
Table 188. Acorda Therapeutics Business Overview
Table 189. Acorda Therapeutics Musculoskeletal Medicine Product
Table 190. Acorda Therapeutics Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 191. Acorda Therapeutics Recent Development
Table 192. Apotex Inc Company Details
Table 193. Apotex Inc Business Overview
Table 194. Apotex Inc Musculoskeletal Medicine Product
Table 195. Apotex Inc Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 196. Apotex Inc Recent Development
Table 197. CorePharma Company Details
Table 198. CorePharma Business Overview
Table 199. CorePharma Musculoskeletal Medicine Product
Table 200. CorePharma Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 201. CorePharma Recent Development
Table 202. Helsinn Company Details
Table 203. Helsinn Business Overview
Table 204. Helsinn Musculoskeletal Medicine Product
Table 205. Helsinn Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 206. Helsinn Recent Development
Table 207. Therabel Company Details
Table 208. Therabel Business Overview
Table 209. Therabel Musculoskeletal Medicine Product
Table 210. Therabel Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 211. Therabel Recent Development
Table 212. Sinopharm Company Details
Table 213. Sinopharm Business Overview
Table 214. Sinopharm Musculoskeletal Medicine Product
Table 215. Sinopharm Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 216. Sinopharm Recent Development
Table 217. Chinoin Company Details
Table 218. Chinoin Business Overview
Table 219. Chinoin Musculoskeletal Medicine Product
Table 220. Chinoin Revenue in Musculoskeletal Medicine Business (2016-2021) & (US$ Million)
Table 221. Chinoin Recent Development
Table 222. Research Programs/Design for This Report
Table 223. Key Data Information from Secondary Sources
Table 224. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Musculoskeletal Medicine Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Patch Features
Figure 4. Capsule Features
Figure 5. Suppositories Features
Figure 6. Injection Features
Figure 7. Suspension Agent Features
Figure 8. Emplastrum Features
Figure 9. Granules Features
Figure 10. Other Features
Figure 11. Global Musculoskeletal Medicine Market Share by Application: 2020 VS 2027
Figure 12. Orthopedic Analgesics Case Studies
Figure 13. Antipyretic And Analgesic Case Studies
Figure 14. Nonsteroidal Anti-Inflammatory Drugs Case Studies
Figure 15. Drugs For Rheumatic Diseases Case Studies
Figure 16. Gout Drug Resistance Case Studies
Figure 17. Medication For Bruising Injuries Case Studies
Figure 18. Myasthenia Gravis Medication Case Studies
Figure 19. Slow Acting Antirheumatic Agent Case Studies
Figure 20. Topical Administration For Joint And Muscle Pain Case Studies
Figure 21. Other Case Studies
Figure 22. Musculoskeletal Medicine Report Years Considered
Figure 23. Global Musculoskeletal Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 24. Global Musculoskeletal Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 25. Global Musculoskeletal Medicine Market Share by Regions: 2020 VS 2027
Figure 26. Global Musculoskeletal Medicine Market Share by Regions (2022-2027)
Figure 27. Global Musculoskeletal Medicine Market Share by Players in 2020
Figure 28. Global Top Musculoskeletal Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Medicine as of 2020
Figure 29. The Top 10 and 5 Players Market Share by Musculoskeletal Medicine Revenue in 2020
Figure 30. Global Musculoskeletal Medicine Revenue Market Share by Type (2016-2021)
Figure 31. Global Musculoskeletal Medicine Revenue Market Share by Type (2022-2027)
Figure 32. North America Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. North America Musculoskeletal Medicine Market Share by Type (2016-2027)
Figure 34. North America Musculoskeletal Medicine Market Share by Application (2016-2027)
Figure 35. North America Musculoskeletal Medicine Market Share by Country (2016-2027)
Figure 36. United States Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Canada Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Europe Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Europe Musculoskeletal Medicine Market Share by Type (2016-2027)
Figure 40. Europe Musculoskeletal Medicine Market Share by Application (2016-2027)
Figure 41. Europe Musculoskeletal Medicine Market Share by Country (2016-2027)
Figure 42. Germany Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. France Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. U.K. Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Italy Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Russia Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Nordic Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Asia-Pacific Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Asia-Pacific Musculoskeletal Medicine Market Share by Type (2016-2027)
Figure 50. Asia-Pacific Musculoskeletal Medicine Market Share by Application (2016-2027)
Figure 51. Asia-Pacific Musculoskeletal Medicine Market Share by Region (2016-2027)
Figure 52. China Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Japan Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. South Korea Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Southeast Asia Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. India Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Australia Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Latin America Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Latin America Musculoskeletal Medicine Market Share by Type (2016-2027)
Figure 60. Latin America Musculoskeletal Medicine Market Share by Application (2016-2027)
Figure 61. Latin America Musculoskeletal Medicine Market Share by Country (2016-2027)
Figure 62. Mexico Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Brazil Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Middle East & Africa Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Middle East & Africa Musculoskeletal Medicine Market Share by Type (2016-2027)
Figure 66. Middle East & Africa Musculoskeletal Medicine Market Share by Application (2016-2027)
Figure 67. Middle East & Africa Musculoskeletal Medicine Market Share by Country (2016-2027)
Figure 68. Turkey Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 69. Saudi Arabia Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 70. UAE Musculoskeletal Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 71. Mylan N.V. Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 72. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 73. UCB S.A. Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 74. Novartis Pharmaceuticals Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 75. Roche Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 76. Hospira Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 77. Valeant Pharmaceuticals International, Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 78. Dr. Reddy's Laboratories Ltd. Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 79. Sun Pharmaceutical Industries Ltd. Co. , Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 80. Sawai PharmaceuticalCo., Ltd Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 81. Endo International Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 82. Hikma Pharmaceuticals Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 83. Fresenius Kabi, LLC Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 84. Boehringer Ingelheim Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 85. Merck Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 86. GSK Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 87. Alter Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 88. Bayer Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 89. Rafa Laboratories Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 90. Grunenthal Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 91. Pfizer Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 92. Sanofi Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 93. Italfarmaco Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 94. Martec USA LLC Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 95. Acorda Therapeutics Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 96. Apotex Inc Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 97. CorePharma Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 98. Helsinn Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 99. Therabel Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 100. Sinopharm Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 101. Chinoin Revenue Growth Rate in Musculoskeletal Medicine Business (2016-2021)
Figure 102. Bottom-up and Top-down Approaches for This Report
Figure 103. Data Triangulation
Figure 104. Key Executives Interviewed

---